2022. Pharmacoepidemiology, impacts of anxiety disorders and anxiolytic abuse before and during the COVID-19 pandemic. Research, Society and Development. 11, 5 (Apr. 2022), e36111528340. DOI:https://doi.org/10.33448/rsd-v11i5.28340.